<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02549326</url>
  </required_header>
  <id_info>
    <org_study_id>295/13/03/03/2012</org_study_id>
    <nct_id>NCT02549326</nct_id>
  </id_info>
  <brief_title>Vitamin D Intervention in Young Adults With Severe Childhood-onset Obesity</brief_title>
  <official_title>Vitamin D Intervention in Young Adults With Severe Childhood-onset Obesity</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Helsinki University Central Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Helsinki University Central Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Obesity is associated with lower total serum 25-hydroxycholecalciferol (S-25OHD)
      concentration. However, the impact of obesity on free S-25OHD is inadequately studied. A
      direct assay for free 25OHD was introduced recently.

      The aim of the study was to evaluate differences in vitamin D metabolism between young adults
      with severe childhood-onset obesity and normal-weight controls. Half of the obese subjects
      and controls will receive placebo and the other half will receive vitamin D3 50 µg daily for
      12 weeks.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>November 2012</start_date>
  <completion_date type="Actual">May 2013</completion_date>
  <primary_completion_date type="Actual">May 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>change in S-25OHD</measure>
    <time_frame>baseline, 6 and 12 weeks</time_frame>
    <description>change in total and free S-25OHD concentrations between obese and controls</description>
  </primary_outcome>
  <primary_outcome>
    <measure>baseline S-25OHD</measure>
    <time_frame>baseline</time_frame>
    <description>differences in total and free S-25OHD between obese and controls</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>baseline vitamin D-binding protein (DBP)</measure>
    <time_frame>baseline</time_frame>
    <description>differences in DBP between obese and controls</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>correlation between S-25OHD and calcium, phosphate, parathyroid hormone (PTH) and osteocalcin</measure>
    <time_frame>baseline, 6 and 12 weeks</time_frame>
    <description>correlation between S-25OHD (total and free) and calcium, phosphate, PTH and osteocalcin</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>change in vitamin D-binding protein (DBP)</measure>
    <time_frame>baseline, 6 and 12 weeks</time_frame>
    <description>change in DBP concentrations between obese and controls</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">42</enrollment>
  <condition>Obesity</condition>
  <arm_group>
    <arm_group_label>Obese, placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo daily for 12 weeks</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Obese, vitamin D</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Vitamin D3 50 µg / daily for 12 weeks</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control, placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo daily for 12 weeks</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control, vitamin D</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Vitamin D3 50 µg / daily for 12 weeks</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>vitamin D</intervention_name>
    <arm_group_label>Obese, vitamin D</arm_group_label>
    <arm_group_label>Control, vitamin D</arm_group_label>
    <other_name>cholecalciferol</other_name>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <arm_group_label>Obese, placebo</arm_group_label>
    <arm_group_label>Control, placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  weight-for-height ratio exceeding 60% before the age of 7 years, according to Finnish
             growth standards and persistence of severe obesity for at least three years in
             childhood

          -  referral to the Children's Hospital, Helsinki University Hospital due to severe
             obesity

          -  at the age of 7 years lived in the greater Helsinki area

        Exclusion Criteria:

          -  endocrine or genetic disorders underlying obesity (e.g. Prader Willi syndrome,
             pseudohypoparathyroidism, hypothyroidism, hypercortisolism, diabetes
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>15 Years</minimum_age>
    <maximum_age>25 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Helena Valta, MD PhD</last_name>
    <role>Study Director</role>
    <affiliation>Helsinki University Central Hospital</affiliation>
  </overall_official>
  <verification_date>September 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 9, 2015</study_first_submitted>
  <study_first_submitted_qc>September 11, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 15, 2015</study_first_posted>
  <last_update_submitted>September 11, 2015</last_update_submitted>
  <last_update_submitted_qc>September 11, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 15, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Helsinki University Central Hospital</investigator_affiliation>
    <investigator_full_name>Elisa Holmlund-Suila</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>Vitamin D</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Obesity</mesh_term>
    <mesh_term>Pediatric Obesity</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamins</mesh_term>
    <mesh_term>Vitamin D</mesh_term>
    <mesh_term>Ergocalciferols</mesh_term>
    <mesh_term>Cholecalciferol</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

